Komori
Changes in Officers2796Pharmarise Holdings CorporationRetail

Notice Regarding Changes in Officers

Subject to approval at the annual general meeting of shareholders scheduled for 28 August 2026, 9 directors and 1 corporate auditor are scheduled to be appointed. Of the directors, 4 will retire upon completion of their terms, and 5 new candidates from inside and outside the Company have been nominated.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 23 July 2026

Incoming appointee

4 items
Scheduled Appointment Date28 August 2026 (to be formally determined following approval at the 40th Annual General Meeting of Shareholders scheduled for 28 August 2026)
Teramoto Naonori (寺本 尚徳)
Previous positionGeneral Manager, Corporate Planning Department, the Company
New positionDirectors
生年月日 11 November 1975入社年 2000
Tanaka Yoshihiro (田仲 義弘)
Previous positionExecutive Director, ファーマライズ株式会社
New positionDirectors
生年月日 9 October 1976入社年 2000
Tsujimoto Mari (辻本 万里)
Previous positionGeneral Manager, Administration Department, the Company
New positionDirectors
生年月日 13 November 1974入社年 2020
Ideguchi Naoko (井手口 直子)
Previous positionProfessor, Graduate School of Pharmaceutical Sciences, Teikyo Heisei University; Professor, Faculty of Pharmaceutical Sciences, Teikyo Heisei University; Council Member, Japanese Society of Palliative Medicine and Pharmaceutical Sciences; Director, Japanese Society of Home Care Pharmacy; Member, Pharmacy Near-Miss Comprehensive Evaluation Subcommittee, Japan Council for Quality Health Care; Delegate, Japanese Society for Health Care Safety; Vice Chair, National Liaison Council for Home Care Support by Pharmacists; Chair, Pharmacy Operations Committee, Tokyo Pharmaceutical Association; Vice Chair, Japanese Society of Community Pharmacy and Pharmaceutical Sciences
New positionDirector (outside director)
生年月日 9 August 1963入社年 Not disclosed

Departing officer

4 items
Date of departure28 August 2026
Matsuura Keiko (松浦 惠子)Stepping down
Former PositionExecutive Director and General Manager, Human Resources Department, the Company
Numata Yutaka (沼田 豊)Stepping down
Former PositionDirectors of the company
Kanno Hiroshi (菅野 洋)Stepping down
Former PositionDirector and General Manager, DX Promotion Department, the Company
Tada Hiroshi (多田 宏)Stepping down
Former PositionOutside Director of the Company
Reason for departure

They will retire upon completion of their terms.

Whether the incumbent will remain in office (whether they will retain their position)

Will not continue as a director

Directors after the change9Number
Shareholders’ meeting approvalRequired. Agenda item: Election of director and corporate auditor candidates. Scheduled date: 28 August 2026
Who is moving to which position
ItemDetails
Resolution date23 July 2026
Scheduled Appointment Date28 August 2026 (to be formally determined following approval at the 40th Annual General Meeting of Shareholders scheduled for 28 August 2026)
Date of departure28 August 2026
Name of appointeeTeramoto Naonori (寺本 尚徳), Tanaka Yoshihiro (田仲 義弘), Tsujimoto Mari (辻本 万里), Ideguchi Naoko (井手口 直子)
Appointee's new positionDirectors, Directors, Directors, Director (outside director)
Appointee's previous positionGeneral Manager, Corporate Planning Department, the Company, Executive Director, ファーマライズ株式会社, General Manager, Administration Department, the Company, Professor, Graduate School of Pharmaceutical Sciences, Teikyo Heisei University; Professor, Faculty of Pharmaceutical Sciences, Teikyo Heisei University; Council Member, Japanese Society of Palliative Medicine and Pharmaceutical Sciences; Director, Japanese Society of Home Care Pharmacy; Member, Pharmacy Near-Miss Comprehensive Evaluation Subcommittee, Japan Council for Quality Health Care; Delegate, Japanese Society for Health Care Safety; Vice Chair, National Liaison Council for Home Care Support by Pharmacists; Chair, Pharmacy Operations Committee, Tokyo Pharmaceutical Association; Vice Chair, Japanese Society of Community Pharmacy and Pharmaceutical Sciences
Appointee's date of birth11 November 1975, 9 October 1976, 13 November 1974, 9 August 1963
Year the appointee joined the Company2000, 2000, 2020, Not disclosed
Name of departing officerMatsuura Keiko (松浦 惠子), Numata Yutaka (沼田 豊), Kanno Hiroshi (菅野 洋), Tada Hiroshi (多田 宏)
Former position of departing officerExecutive Director and General Manager, Human Resources Department, the Company, Directors of the company, Director and General Manager, DX Promotion Department, the Company, Outside Director of the Company
Reason for departureThey will retire upon completion of their terms.
Whether the incumbent will remain in officeWill not continue as a director
Number of directors after the change9 (including 3 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. Agenda item: Election of director and corporate auditor candidates. Scheduled date: 28 August 2026
Items this document does not state (7)
Number of shares held by the appointeeNew position of departing officerReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The 4 retiring directors will retire upon completion of their terms. No individual explanations have been provided for the nomination of the director and corporate auditor candidates.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Officers | Pharmarise Holdings Corporation (2796) timely disclosure | Komori